Overall, our findings indicate that SchA may mitigate the effects of diabetes-related cortical inflammation, insulin resistance, and iron overload, safeguarding synaptic and neuronal plasticity and eventually resolving cognitive impairment. This evidence concerns the gene INS and diabetes mellitus.